在大型现实世界队列中，种族/族裔和保险与弥漫性大 B 细胞淋巴瘤患者的生存相关。
Association of race/ethnicity and insurance with survival in patients with diffuse large B-cell lymphoma in a large real-world cohort.
发表日期：2024 Aug
作者：
Yanling Jin, Jia Li, Yong Mun, Anthony Masaquel, Sylvia Hu, Juliana M L Biondo
来源：
Cell Death & Disease
摘要：
大型现实世界 EHR 数据集 Flatiron 表明，种族与 DLBCL 患者较差的生存率没有显着相关。对于年龄 <65 岁的 DLBCL 患者，医疗补助保险状况与较差的总体生存率和二线治疗时间或全因死亡显着相关。© 2024 作者。约翰·威利出版的癌症医学
The large real-world EHR dataset Flatiron has shown that race was not significantly associated with poorer survival in patients with DLBCL. Medicaid insurance status was significantly associated with poorer overall survival and time to second-line therapy or death due to any cause in patients with DLBCL aged <65 years.© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.